International Alcohol Control Online Symposium Held: Focusing on Global and Low- and Middle-Income Country Response Strategies
MACAU, June 30, 2026 /PRNewswire/ -- The International Alcohol Control Online Symposium, organized by experts from the World Health Organization (WHO), the International Agency for Research on Cancer (IARC) Biobank and Cohort Building Network (BCNet), and other institutions, has reaffirmed that alcohol is a Group 1 carcinogen. Any level of consumption increases health risks, and it is generally...
Innovent Biologics and Lilly Enter into Commercialization Agreement for Verzenios® (abemaciclib) in Mainland China
SAN FRANCISCO and SUZHOU, China, June 30, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major disease areas, and Eli Lilly and Company (NYSE: LLY) today jointly announced that they have entered into a...
Xellar Raises $50 Million Series A Financing to Build the Future of 3D Bio Intelligence
Financing will accelerate the development of human-relevant biological data infrastructure, virtual cell technologies, and next-generation drug discovery BOSTON, June 30, 2026 /PRNewswire/ -- Xellar Biosystems today announced the closing of $50 million in Series A and A+ financing to advance its vision of building the world's leading 3D Bio Intelligence platform. The financing will support the expansion of...
Anta Group’s HEMIN Foundation Releases 2025 Annual Report; RMB 2 Billion Donation-Funded Public Tertiary Hospital to Open Within the Year
JINJIANG, China, June 30, 2026 /PRNewswire/ -- Today, Anta Group's HEMIN Foundation released its 2025 Annual Report. Since its establishment in 2021 with a RMB 10 billion endowment from the founding family of ANTA Group, the Foundation has focused on three key areas: healthcare, sports and education, and community care. As of the end of 2025, cumulative donations...
Ozelle to Debut O-Cyte 1 at ADLM 2026, Bringing Speed to AI-Powered Morphology Intelligence
The upcoming global debut is set to mark a step forward in AI-powered hematology, advancing the 4th Generation of Hematology Analysis ANAHEIM, Calif. and FRANKFURT, Germany, June 30, 2026 /PRNewswire/ -- Ozelle will unveil O-Cyte 1, its newest automated hematology analyzer, at ADLM 2026 in California. Making its global debut at one of the leading international events for...
BRAHMA AI, Hakuhodo Technologies Partner to Scale High-Fidelity Digital Humans Across Japan and APAC
LONDON and TOKYO, June 29, 2026 /PRNewswire/ -- BRAHMA AI and Hakuhodo Technologies today announced a strategic partnership to develop, commercialize, and deploy high-fidelity digital humans at enterprise scale across Japan and the Asia-Pacific (APAC) region. Digital Human (ATMAN) of Hibari Misora, featured in the BS Nippon TV...
Yili Group Showcases Dairy Innovation and Functional Product Development at the 19th Global Dairy Congress
CAMBRIDGE, England, June 29, 2026 /PRNewswire/ -- From June 17 to 18, the 19th Global Dairy Congress, themed "Fit for Purpose," was held in Barcelona, Spain, bringing together dairy industry leaders and representatives from around the globe. On the opening day, Dr. Ignatius Szeto, Vice President of Yili Group, delivered a keynote speech titled "Creating High Value Functional Product...
TrilliumBiO and The LAM Foundation Partner to Advance LAM Awareness and Education
Efforts include support for earlier diagnosis through LAMair™, TrilliumBiO's newly developed VEGF‑D test ROCKVILLE, Md. and CINCINNATI, June 29, 2026 /PRNewswire/ -- TrilliumBiO, a leader in biomarker discovery and precision diagnostics, today announced a commitment to raising awareness of lymphangioleiomyomatosis (LAM), a rare, progressive lung disease that primarily affects women. As...
Alebund Pharmaceuticals (09637.HK) Debuts on the HKEx Main Board
Deepening Its Commitment to Kidney Disease and Accelerating Toward Becoming a Global Leader in Renal Innovation SHANGHAI, June 29, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; stock code: 09637.HK), a biopharmaceutical company focused on kidney disease, with the broadest pipeline by renal indication coverage, today listed on the Main Board of The Stock Exchange...
Health In Tech Added to Membership of Russell Microcap® Index
STUART, Fla., June 29, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or the "Company") was added as a member of the Russell Microcap® Index, effective when the U.S. market opens on June 29, 2026, as part of the 2026 Russell U.S. indexes reconstitution. ...
